Evidence-Based Recommendations on the Use of Casirivimab + Imdevimab, and Sotrovimab for Adults in Ontario

Jacob J. Bailey,Andrew M. Morris,Sally Bean,Eyal Cohen,Jonathan Gubbay,Yona Lunsky,Samir Patel,Vanessa Tran,Kathrine J. Miller, Zainab Abdurrahman,Stephanie Carlin,William Ciccotelli,Jennifer Gibson,Jennie Johnstone,Tiffany Kan,Bradley Langford,Elizabeth Leung,Ullanda Neil, Sumit Raybardan,Janet Smylie,Anupma Wadhwa,Peter Jüni,Menaka Pai

semanticscholar（2021）

引用 0|浏览9

暂无评分

摘要

chemotherapeutic agents classified as severely immunosuppressive, tumor-necrosis factor (TNF) blockers, and other biologic agents that are immunosuppressive or immunomodulatory. These individuals should have a reasonable expectation for 1-year survival prior to getting infected with SARS-CoV-2.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要